Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Am J Psychiatry. 2014 Jun 1;171(6):640–648. doi: 10.1176/appi.ajp.2014.13121625

Table 3.

Proportion of participants who met criteria for PTSD.

D-cycloserine
(N = 53)
Alprazolam
(N = 50)
Placebo
(N = 53)
Did not
meet
Criteria
Met
Criteria
Did not
meet
Criteria
Met
Criteria
Did not
meet
Criteria
Met
Criteria
post-tx 6 (21.4)a 22 (78.6) 9 (25.7)a 26 (74.3) 9 (26.5)a 24 (73.5)
3-month 7 (35.0)a 13 (65.0) 5 (20.8)b 19 (79.2) 12 (52.2)a 11 (47.8)
6-month 7 (41.2)a 10 (58.8) 6 (24.0)a 13 (68.4) 13 (56.5)a 10 (43.5)
12-month 9 (52.9)a 8 (47.1)a 8 (36.4)a 11 (57.8) 9 (45.0)a 11 (55.0)

Note: post-tx = post-treatment assessment; Values are raw numbers and scores in parentheses are percentages. Superscripts denote differences across groups within each time points at α of .05